Healthcare provider profile · identity verified

Robert Scott Barrett, DO

Internal Medicine · GAINESVILLE, GA · NPI 1780902411

Profile state: partd only Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

We did not find matching Open Payments records for this doctor in 2025.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

We did not find matching Open Payments records for this doctor in the selected program year.

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Analysis 1 · Payment-linked products

Products named in Open Payments records

No payment-linked product analysis is available because no matching General Payment records were found for the selected year.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

There is no payer-company set available for this comparison.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Levothyroxine Sodium	Levothyroxine Sodium	528	145
Rosuvastatin Calcium	Rosuvastatin Calcium	427	131
Atorvastatin Calcium	Atorvastatin Calcium	373	109
Lisinopril	Lisinopril	311	91
Losartan Potassium	Losartan Potassium	280	80
Amlodipine Besylate	Amlodipine Besylate	275	91
Omeprazole	Omeprazole	234	63
Tamsulosin Hcl	Tamsulosin Hcl	187	57
Hydrochlorothiazide	Hydrochlorothiazide	165	44
Gabapentin	Gabapentin	161	52
Trazodone Hcl	Trazodone Hcl	156	53
Pantoprazole Sodium	Pantoprazole Sodium	150	48
Metoprolol Succinate	Metoprolol Succinate	143	42
Ozempic	Semaglutide	129	27
Tramadol Hcl	Tramadol Hcl	125	30
Alprazolam	Alprazolam	122	30
Carvedilol	Carvedilol	116	33
Simvastatin	Simvastatin	116	37
Hydrocodone-Acetaminophen	Hydrocodone/Acetaminophen	115	13
Allopurinol	Allopurinol	114	35
Sertraline Hcl	Sertraline Hcl	107	28
Famotidine	Famotidine	103	30
Citalopram Hbr	Citalopram Hydrobromide	95	26
Metformin Hcl	Metformin Hcl	95	36
Prednisone	Prednisone	92	61
Venlafaxine Hcl Er	Venlafaxine Hcl	88	25
Zolpidem Tartrate	Zolpidem Tartrate	88	27
Potassium Chloride	Potassium Chloride	87	25
Escitalopram Oxalate	Escitalopram Oxalate	86	24
Trulicity	Dulaglutide	85	13
Montelukast Sodium	Montelukast Sodium	84	28
Ezetimibe	Ezetimibe	83	28
Lisinopril-Hydrochlorothiazide	Lisinopril/Hydrochlorothiazide	82	24
Metformin Hcl Er	Metformin Hcl	80	28
Clonazepam	Clonazepam	73	12
Metoprolol Tartrate	Metoprolol Tartrate	70	25
Finasteride	Finasteride	68	22
Lorazepam	Lorazepam	67	15
Jardiance	Empagliflozin	65	18
Losartan-Hydrochlorothiazide	Losartan/Hydrochlorothiazide	64	18
Pravastatin Sodium	Pravastatin Sodium	63	20
Oxybutynin Chloride Er	Oxybutynin Chloride	62	13
Amoxicillin-Clavulanate Potass	Amoxicillin/Potassium Clav	60	47
Esomeprazole Magnesium	Esomeprazole Magnesium	60	14
Albuterol Sulfate Hfa	Albuterol Sulfate	59	33
Eliquis	Apixaban	56	suppressed
Diclofenac Sodium	Diclofenac Sodium	55	25
Hydralazine Hcl	Hydralazine Hcl	55	17
Diazepam	Diazepam	52	suppressed
Fluticasone Propionate	Fluticasone Propionate	52	18
Januvia	Sitagliptin Phosphate	48	suppressed
Furosemide	Furosemide	45	13
Buspirone Hcl	Buspirone Hcl	43	15
Clopidogrel	Clopidogrel Bisulfate	41	14
Nebivolol Hcl	Nebivolol Hcl	40	suppressed
Omega-3 Acid Ethyl Esters	Omega-3 Acid Ethyl Esters	39	suppressed
Duloxetine Hcl	Duloxetine Hcl	38	12
Spironolactone	Spironolactone	38	11
Benazepril Hcl	Benazepril Hcl	37	suppressed
Cyclobenzaprine Hcl	Cyclobenzaprine Hcl	35	11
Linzess	Linaclotide	35	suppressed
Mounjaro	Tirzepatide	34	suppressed
Azithromycin	Azithromycin	33	26
Atenolol	Atenolol	32	suppressed
Glipizide Er	Glipizide	32	13
Fluoxetine Hcl	Fluoxetine Hcl	31	suppressed
Myrbetriq	Mirabegron	31	suppressed
Quetiapine Fumarate	Quetiapine Fumarate	31	suppressed
Synthroid	Levothyroxine Sodium	31	11
Bupropion Hcl Sr	Bupropion Hcl	30	suppressed
Doxepin Hcl	Doxepin Hcl	30	13
Doxycycline Monohydrate	Doxycycline Monohydrate	29	28
Lovastatin	Lovastatin	29	suppressed
Bupropion Xl	Bupropion Hcl	28	14
Cefdinir	Cefdinir	26	23
Glimepiride	Glimepiride	26	suppressed
Meloxicam	Meloxicam	25	suppressed
Paxlovid	Nirmatrelvir/Ritonavir	25	25
Methylprednisolone	Methylprednisolone	24	23
Fenofibrate	Fenofibrate	23	suppressed
Nifedipine Er	Nifedipine	23	suppressed
Oxycodone Hcl	Oxycodone Hcl	23	suppressed
Breo Ellipta	Fluticasone/Vilanterol	22	suppressed
Clonidine Hcl	Clonidine Hcl	22	11
Valacyclovir	Valacyclovir Hcl	22	12
Celecoxib	Celecoxib	21	suppressed
Nystatin	Nystatin	21	12
Farxiga	Dapagliflozin Propanediol	20	suppressed
Meclizine Hcl	Meclizine Hcl	20	suppressed
Brimonidine Tartrate	Brimonidine Tartrate	19	suppressed
Ondansetron Odt	Ondansetron	19	13
Butalbital-Acetaminophen-Caffe	Butalb/Acetaminophen/Caffeine	18	suppressed
Doxazosin Mesylate	Doxazosin Mesylate	18	suppressed
Latanoprost	Latanoprost	18	suppressed
Promethazine Hcl	Promethazine Hcl	18	suppressed
Telmisartan	Telmisartan	18	suppressed
Alendronate Sodium	Alendronate Sodium	17	suppressed
Propranolol Hcl Er	Propranolol Hcl	17	suppressed
Sulfamethoxazole-Trimethoprim	Sulfamethoxazole/Trimethoprim	17	13
Tizanidine Hcl	Tizanidine Hcl	17	suppressed
Topiramate	Topiramate	17	suppressed
Torsemide	Torsemide	17	suppressed
Xarelto	Rivaroxaban	17	suppressed
Ciprofloxacin Hcl	Ciprofloxacin Hcl	16	14
Colchicine	Colchicine	16	suppressed
Olmesartan Medoxomil	Olmesartan Medoxomil	16	suppressed
Paroxetine Hcl	Paroxetine Hcl	16	suppressed
Ropinirole Hcl	Ropinirole Hcl	16	suppressed
Gemfibrozil	Gemfibrozil	15	suppressed
Janumet	Sitagliptin Phos/Metformin Hcl	15	suppressed
Ketorolac Tromethamine	Ketorolac Tromethamine	15	suppressed
Mupirocin	Mupirocin	15	suppressed
Triamcinolone Acetonide	Triamcinolone Acetonide	15	12
Candesartan Cilexetil	Candesartan Cilexetil	14	suppressed
Fenofibrate	Fenofibrate Nanocrystallized	14	suppressed
Memantine Hcl	Memantine Hcl	14	suppressed
Memantine Hcl Er	Memantine Hcl	14	suppressed
Pramipexole Dihydrochloride	Pramipexole Di-Hcl	14	suppressed
Ramipril	Ramipril	14	suppressed
Valsartan	Valsartan	14	suppressed
Acetazolamide	Acetazolamide	13	suppressed
Balsalazide Disodium	Balsalazide Disodium	13	suppressed
Bisoprolol Fumarate	Bisoprolol Fumarate	13	suppressed
Colesevelam Hcl	Colesevelam Hcl	13	suppressed
Diltiazem 24hr Er	Diltiazem Hcl	13	suppressed
Fenofibrate	Fenofibrate,micronized	13	suppressed
Lansoprazole	Lansoprazole	13	suppressed
Mirtazapine	Mirtazapine	13	suppressed
Sulindac	Sulindac	13	suppressed
Testosterone Cypionate	Testosterone Cypionate	13	suppressed
Wixela Inhub	Fluticasone Propion/Salmeterol	13	suppressed
Acyclovir	Acyclovir	12	suppressed
Bisoprolol-Hydrochlorothiazide	Bisoprolol/Hydrochlorothiazide	12	suppressed
Methocarbamol	Methocarbamol	12	suppressed
Primidone	Primidone	12	suppressed
Triamterene-Hydrochlorothiazid	Triamterene/Hydrochlorothiazid	12	suppressed
Amlodipine Besylate-Benazepril	Amlodipine Besylate/Benazepril	11	suppressed
Cyanocobalamin Injection	Cyanocobalamin (Vitamin B-12)	11	suppressed
Ezetimibe-Simvastatin	Ezetimibe/Simvastatin	11	suppressed
Irbesartan	Irbesartan	11	suppressed
Levocetirizine Dihydrochloride	Levocetirizine Dihydrochloride	11	suppressed
Tradjenta	Linagliptin	11	suppressed
Valsartan-Hydrochlorothiazide	Valsartan/Hydrochlorothiazide	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	—	—	—	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error